Portfolio company
Veirulence Ltd
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops non-antibiotic small molecules targeting bacterial virulence factors for healthcare providers treating resistant hospital-acquired infections.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
MetalloBio
This company develops antimicrobial compounds and medical device coatings to combat antibiotic resistance for the pharmaceutical and healthcare sectors.
Omnix Medical
This biopharmaceutical company develops novel antibiotic agents for patients suffering from life-threatening, drug-resistant bacterial infections.
Adjutecpharma
This company develops antibiotic resistance breakers for healthcare providers to treat patients with life-threatening bacterial infections.
Acurx Pharmaceuticals
This biopharmaceutical company develops small molecule antibiotics to treat patients with bacterial infections caused by priority pathogens.
Calixa Therapeutics
This biopharmaceutical company develops novel antibiotics to treat serious infections caused by multi-drug-resistant pathogens for hospital patients.
Eradivir
This biotechnology company develops small molecule immunotherapies that target viral infections and cancers for healthcare providers and patients.
Arpida AG
This biopharmaceutical company develops novel antibiotics for hospital patients to treat severe infections caused by drug-resistant bacteria.
Arpida
This company develops antimicrobial drugs and broad-spectrum antibiotics to treat patients with severe bacterial infections requiring hospital treatment.
